Basit öğe kaydını göster

beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

dc.contributor.authorFrelih, Nina
dc.contributor.authorBoni, Elisa
dc.contributor.authorBozek, Andrzej
dc.contributor.authorChelminska, Marta
dc.contributor.authorErnst, Barbara
dc.contributor.authorGawlik, Radoslaw
dc.contributor.authorHawranek, Thomas
dc.contributor.authorHoetzenecker, Wolfram
dc.contributor.authorJimenez Blanco, Aranzazu
dc.contributor.authorKita, Karolina
dc.contributor.authorKendirlinan, Resat
dc.contributor.authorKosnik, Mitja
dc.contributor.authorLaipold, Karin
dc.contributor.authorLang, Roland
dc.contributor.authorMarchi, Francesco
dc.contributor.authorMauro, Marina
dc.contributor.authorNittner-Marszalska, Marita
dc.contributor.authorPoziomkowska-Gesicka, Iwona
dc.contributor.authorPravettoni, Valerio
dc.contributor.authorPreziosi, Donatella
dc.contributor.authorQuercia, Oliviero
dc.contributor.authorReider, Norbert
dc.contributor.authorRosiek-Biegus, Marta
dc.contributor.authorRuiz-Leon, Berta
dc.contributor.authorSchrautzer, Christoph
dc.contributor.authorSerrano, Pilar
dc.contributor.authorSin, Aytul
dc.contributor.authorSİN, BETÜL AYŞE
dc.contributor.authorStoevesandt, Johanna
dc.contributor.authorTrautmann, Axel
dc.contributor.authorVachova, Martina
dc.contributor.authorArzt-Gradwohl, Lisa
dc.contributor.authorGelincik, Asli
dc.contributor.authorSturm, Gunter Johannes
dc.contributor.authorHerzog, Sereina Annik
dc.contributor.authorAberer, Werner
dc.contributor.authorAlfaya Arias, Teresa
dc.contributor.authorAntolin-Amerigo, Dario
dc.contributor.authorBonadonna, Patrizia
dc.date.accessioned2021-12-10T11:32:54Z
dc.date.available2021-12-10T11:32:54Z
dc.identifier.citationSturm G. J. , Herzog S. A. , Aberer W., Alfaya Arias T., Antolin-Amerigo D., Bonadonna P., Boni E., Bozek A., Chelminska M., Ernst B., et al., "beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy", ALLERGY, 2021
dc.identifier.issn0105-4538
dc.identifier.otherav_84849fae-0ffc-4c34-94df-f6c0057782a0
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/172105
dc.identifier.urihttps://doi.org/10.1111/all.14785
dc.description.abstractBackground There is controversy whether taking beta-blockers or ACE inhibitors (ACEI) is a risk factor for more severe systemic insect sting reactions (SSR) and whether it increases the number or severity of adverse events (AE) during venom immunotherapy (VIT).
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectTemel Bilimler
dc.subjectGeneral Immunology and Microbiology
dc.subjectImmunology
dc.subjectImmunology and Allergy
dc.subjectLife Sciences
dc.subjectALERJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri
dc.titlebeta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy
dc.typeMakale
dc.relation.journalALLERGY
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.contributor.firstauthorID2605767


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster